GTR Test Accession:
Help
GTR000613104.2
Last updated in GTR:
2024-05-02
View version history
GTR000613104.2,
last updated:
2024-05-02
GTR000613104.1,
registered in GTR:
2023-11-09
Last annual review date for the lab: 2024-05-28
LinkOut
At a Glance
Methods (1):
Help
Biochemical Genetics - Analyte: High-performance liquid chromatography (HPLC)
Target population: Help
Evaluation of patients who present with signs or symptoms suggestive …
Clinical validity:
Help
Not provided
Clinical utility:
Help
Establish or confirm diagnosis
Ordering Information
Offered by:
Help
Test short name:
Help
FQPPS
Specimen Source:
Help
Who can order: Help
- Genetic Counselor
- Health Care Provider
- Licensed Dentist
- Licensed Physician
- Nurse Practitioner
- Physician Assistant
- Public Health Mandate
- Registered Nurse
Lab contact:
Help
Gisele (Gessi) Bentz Pino, MS, CGC, Certified Genetic counselor, CGC, Genetic Counselor
[email protected]
1-800-533-1710
[email protected]
1-800-533-1710
Contact Policy:
Help
Laboratory can only accept contact from health care providers. Patients/families are encouraged to discuss genetic testing options with their health care provider.
How to Order:
Help
https://www.mayocliniclabs.com/test-catalog/overview/81652#Specimen
Order URL
Order URL
Test development:
Help
Test developed by laboratory (no manufacturer test name)
Informed consent required:
Help
Based on applicable state law
Pre-test genetic counseling required:
Help
Decline to answer
Post-test genetic counseling required:
Help
Decline to answer
Recommended fields not provided:
Test strategy
Conditions
Help
Total conditions: 7
Condition/Phenotype | Identifier |
---|
Test Targets
Analytes
Help
Total analytes: 1
Analyte | Associated Condition |
---|
Methodology
Total methods: 1
Method Category
Help
Test method
Help
Instrument *
Analyte
High-performance liquid chromatography (HPLC)
* Instrument: Not provided
Clinical Information
Test purpose:
Help
Diagnosis;
Screening
Clinical utility:
Help
Establish or confirm diagnosis
View citations (1)
- Tortorelli S, Kloke K, Raymond K: Disorders of porphyrin metabolism. In: Dietzen DJ, Bennett MJ, Wong EDD, eds. Biochemical and Molecular Basis of Pediatric Disease. 4th ed. AACC Press; 2010:307-324
Target population:
Help
Evaluation of patients who present with signs or symptoms suggestive of porphyria cutanea tarda, hereditary coproporphyria, variegate porphyria, congenital erythropoietic porphyria, erythropoietic protoporphyria, or X-linked dominant protoporphyria.
Variant Interpretation:
What is the protocol for interpreting a variation as a VUS?
Help
N/A
N/A
Will the lab re-contact the ordering physician if variant interpretation changes?
Help
Not provided. N/A
Not provided. N/A
Research:
Is research allowed on the sample after clinical testing is complete?
Help
N/A
N/A
Recommended fields not provided:
Clinical validity,
Are family members with defined clinical status recruited to assess significance of VUS without charge?,
Will the lab re-contact the ordering physician if variant interpretation changes?,
Sample negative report,
Sample positive report
Technical Information
Test Procedure:
Help
The porphyrins are separated according to numbers of carboxyl units and isomer status. Analytic specificity is based on the combination of chromatographic behavior and the uniqueness of the porphyrins among substances in human specimens in terms of fluorescence spectra. Components quantified are 10 specific porphyrins of isomer series I and …
View more
Availability:
Help
Tests performed
Entire test performed in-house
Entire test performed in-house
Analytical Validity:
Help
Recovery was used to assess accuracy; mean recovery was 100%. Intra assay precision was performed at 5 levels: CV results ranged from 0% to 21.07% (N=5 each). Inter assay precision was performed at 5 levels: CV results ranged from 1.88% to 28.29%(N=5 each). The analytical measurement range is analyte dependent …
View more
Assay limitations:
Help
Heme from red meat can contribute to fecal protoporphyrin concentrations and cause a misleading indication of erythropoietic protoporphyria, X-linked dominant protoporphyria, or variegate porphyria. Aspirin ingestion may cause minimal gastrointestinal bleeding, leading to false elevations of protoporphyrin. Specimen submitted should contain at least 100 g of feces. Specimens smaller than …
View more
Proficiency testing (PT):
Is proficiency testing performed for this test?
Help
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
IPNET, RCPA
Description of PT method: Help
Formal PT program.
Description of internal test validation method: Help
This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.
Yes
Method used for proficiency testing: Help
Formal PT program
PT Provider: Help
IPNET, RCPA
Description of PT method: Help
Formal PT program.
Description of internal test validation method: Help
This test was laboratory developed, and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements.
VUS:
Software used to interpret novel variations
Help
N/A
Laboratory's policy on reporting novel variations Help
N/A
N/A
Laboratory's policy on reporting novel variations Help
N/A
Recommended fields not provided:
Test Confirmation,
Citations to support assay limitations,
Citations to support internal test validation method,
Citations for Analytical validity,
Major CAP category, CAP category, CAP test list
Regulatory Approval
FDA Review:
Help
Category:
FDA exercises enforcement discretion
Additional Information
Reviews:
Clinical resources:
Consumer resources:
IMPORTANT NOTE:
NIH does not independently verify information submitted to GTR; it relies on submitters to provide information that is accurate and not misleading.
NIH makes no endorsements of tests or laboratories listed in GTR. GTR is not a substitute for medical advice.
Patients and consumers
with specific questions about a genetic test should contact a health care provider or a genetics professional.